| Date Filed | Type | Description |
| 05/16/2023 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Bought 11,985 shares
@ $1.1289, valued at
$13.5k
Bought 75,015 shares
@ $1.1214, valued at
$84.1k
|
|
| 01/19/2023 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 92,950 shares
@ $0
Granted 557,050 options to buy
@ $1.97, valued at
$1.1M
|
|
| 07/27/2022 |
4/A
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Exercised 100,000 options to buy
@ $2.09, valued at
$209k
|
|
| 07/26/2022 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Exercised 100,000 options to buy
@ $2.09, valued at
$209k
|
|
| 06/03/2022 |
4
| Sherman Michael A. (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 11,600 options to buy
@ $3.43, valued at
$39.8k
|
|
| 01/20/2022 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 875,000 options to buy
@ $5.62, valued at
$4.9M
|
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/26/2021 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 700,000 options to buy
@ $9.28, valued at
$6.5M
|
|
| 12/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2020 |
4
| Sherman Michael A. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 2,018 shares
@ $0 |
|
| 04/15/2020 |
3
| Sherman Michael A. (Director) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 03/16/2020 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Bought 72,995 shares
@ $1.4474, valued at
$105.7k
|
|
| 01/23/2020 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 632,500 options to buy
@ $2.08, valued at
$1.3M
|
|
| 05/20/2019 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Bought 30,000 shares
@ $3.4772, valued at
$104.3k
|
|
| 04/09/2019 |
4
| Sherman Michael A. (CEO) has filed a Form 4 on CHIMERIX INC|
Txns:
| Granted 1,250,000 options to buy
@ $2.09, valued at
$2.6M
|
|
| 04/09/2019 |
3
| Sherman Michael A. (CEO) has filed a Form 3 on CHIMERIX INC |
| 12/21/2018 |
4
| Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 243,739 shares
@ $24, valued at
$5.8M
Disposed/sold 19,919 shares
@ $24, valued at
$478.1k
Disposed/sold 7,188 shares
@ $24, valued at
$172.5k
Disposed/sold 5,000 shares
@ $24, valued at
$120k
Disposed/sold 23,438 shares
@ $24, valued at
$562.5k
Disposed/sold 62,500 shares
@ $24, valued at
$1.5M
Disposed/sold 37,500 shares
@ $24, valued at
$900k
Disposed/sold 20,800 options to buy
@ $9.05, valued at
$188.2k
Disposed/sold 74,998 options to buy
@ $3.55, valued at
$266.2k
Disposed/sold 58,719 options to buy
@ $9.86, valued at
$579k
Disposed/sold 36,000 options to buy
@ $11.11, valued at
$400k
|
|
| 12/19/2018 |
4
| Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 84,112 shares
@ $0
Exercised 5,330 options to buy
@ $2.54, valued at
$13.5k
Exercised 10,035 options to buy
@ $2.54, valued at
$25.5k
Exercised 15,706 options to buy
@ $3.82, valued at
$60k
Exercised 39,200 options to buy
@ $9.05, valued at
$354.8k
Exercised 25,002 options to buy
@ $3.55, valued at
$88.8k
Exercised 11,281 options to buy
@ $9.86, valued at
$111.2k
Exercised 9,000 options to buy
@ $11.11, valued at
$100k
Exercised 3 options to buy
@ $5.1, valued at
$15.3
Exercised 2 options to buy
@ $3.18, valued at
$6.4 |
|
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2018 |
4
| Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 37,500 shares
@ $0
Granted 225,000 options to buy
@ $3.01, valued at
$677.3k
|
|
| 02/06/2018 |
4
| Sherman Michael A. (President and CEO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Exercised 5,453 options to buy
@ $3.06, valued at
$16.7k
|
|
| 10/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Sherman Michael A. (Director) has filed a Form 4 on Mead Johnson Nutrition Co|
Txns:
| Granted 1,709 restricted stock units
@ $0
Exercised 2,373 restricted stock units
@ $0 |
|
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2016 |
4
| Sherman Michael A. (COO and CFO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 14,375 shares
@ $0
Paid exercise price by delivering 1,771 shares
@ $3.18, valued at
$5.6k
Paid exercise price by delivering 694 shares
@ $3.02, valued at
$2.1k
Granted 86,250 options to buy
@ $3.18, valued at
$274.3k
|
|
| 03/02/2012 |
4
| Sherman Michael A. (CFO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 100,000 options to buy
@ $3.55, valued at
$355k
|
|
| 12/16/2011 |
4
| Sherman Michael A. (CFO) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Exercised 13,089 options to buy
@ $1.91, valued at
$25k
Exercised 7,853 options to buy
@ $2.1, valued at
$16.5k
|
|
|